7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Mandibular Diseases D008336 5 associated lipids
Bone Resorption D001862 7 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Bone Neoplasms D001859 5 associated lipids
Fractures, Bone D050723 4 associated lipids
Osteoarthritis D010003 4 associated lipids
Carcinoma D002277 18 associated lipids
Osteonecrosis D010020 5 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Li G et al. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. 2015 Int J Clin Exp Pathol pmid:26884838
Miao Q et al. Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway. 2015 Int J Clin Exp Pathol pmid:26617755
Goswami S and Sharma-Walia N Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. 2015 BMC Cancer pmid:26608463
Mrozikiewicz-Rakowska B et al. Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. 2015 J. Physiol. Pharmacol. pmid:26579581
Kurz K et al. Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. 2015 Dis. Markers pmid:26576067
Liu W et al. Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. 2015 PLoS ONE pmid:26571489
Schiro A et al. Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. 2015 Sci Rep pmid:26564003
Mizuno M et al. Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. 2015 Sci Rep pmid:26561427
Morisawa T et al. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. 2015 Int Heart J pmid:26549398
Beuselinck B et al. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. 2015 Br. J. Cancer pmid:26528707
Rewiuk K and Grodzicki T Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. 2015 Biomed Res Int pmid:26504794
Marley K et al. Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL. 2015 Exp. Cell Res. pmid:26254896
McCarthy NI et al. Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development. 2015 J. Immunol. pmid:26254339
Grosjean F et al. Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. 2015 PLoS ONE pmid:26247358
Lewis JR et al. Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. 2015 PLoS ONE pmid:26222774
Audo R et al. Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. 2015 Arthritis Res. Ther. pmid:26220665
Wang J et al. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. 2015 PLoS ONE pmid:26218592
Kao SY and Stankovic KM Transactivation of human osteoprotegerin promoter by GATA-3. 2015 Sci Rep pmid:26216189
Kassem A et al. TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. 2015 FASEB J. pmid:26207027
Yang H et al. A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. 2015 Int J Clin Exp Pathol pmid:26191212
Pitari MR et al. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. 2015 Oncotarget pmid:26160841
Hsu BG et al. High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. 2015 Tohoku J. Exp. Med. pmid:26156285
Ye M et al. Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. 2015 Mol Med Rep pmid:26459042
Goyden J et al. The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. 2015 PLoS ONE pmid:26030441
Beederman M et al. Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. 2015 Plast. Reconstr. Surg. pmid:26017615
Tanaka Y et al. [Mesenchymal stem cells for the treatment and repair of inflammatory arthritis]. 2015 Nihon Rinsho Meneki Gakkai Kaishi pmid:26016635
Priyadarshi S et al. Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. 2015 Ann. Hum. Genet. pmid:25998045
Yang Y et al. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. 2015 J. Biol. Chem. pmid:25979341
Ehlken C et al. Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. 2015 PLoS ONE pmid:25978399
Ardeshirpour L et al. OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. 2015 Endocrinology pmid:25961842
Reveille JD Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. 2015 Clin. Rheumatol. pmid:25939520
Bortolin RH et al. Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. 2015 PLoS ONE pmid:25933189
Wei J et al. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. 2015 Mol Med Rep pmid:25891179
Su F et al. Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. 2015 Stem Cell Res Ther pmid:25888745
Shen Y et al. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. 2015 BMC Complement Altern Med pmid:25887296
Yang X et al. Effects of TGF-β1 on OPG/RANKL expression of cementoblasts and osteoblasts are similar without stress but different with mechanical compressive stress. 2015 ScientificWorldJournal pmid:25685846
Chung CP et al. A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. 2015 Int J Mol Sci pmid:25679449
HaDuong JH et al. Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. 2015 Int. J. Cancer pmid:25648303
Higgs JT et al. Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. 2015 Mol. Cancer Res. pmid:25636966
Lanza D et al. Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. 2015 PLoS ONE pmid:25635832
Dale MD et al. Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. 2015 Int J Mol Sci pmid:25625518
Ottewell PD et al. OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. 2015 Int. J. Cancer pmid:25603921
Son GY et al. Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. 2015 J. Dent. Res. pmid:25595364
Oostra DR et al. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. 2015 Mol. Cell. Endocrinol. pmid:25575458
Recker EN et al. A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. 2015 J. Periodontol. pmid:25269523
Hung JY et al. Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. 2015 Int. J. Oncol. pmid:25738754
Nash LA et al. Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. 2015 Mol Nutr Food Res pmid:25488131
Jin Y et al. Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. 2015 Angle Orthod pmid:24810489
Kelesidis T et al. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. 2014 Jul-Sep AIDS Rev pmid:25102334
Bastos MF et al. Impact of caffeine and/or estrogen deficiency on trabecular bone area and healing: a study in rats. 2014 Jan-Feb Int J Oral Maxillofac Implants pmid:24451874

Table of Content